Innovation without IP? Lessons from Household, Healthcare, and Producer Innovation – University of Copenhagen

CeBIL > Calendar > Innovation without IP?...

Innovation without IP? Lessons from Household, Healthcare, and Producer Innovation

Traditional innovation models emphasize the prominent role of the producer as the source of innovation, and this logic still often dominates research, practice and policy approaches to innovation. However, we know from numerous examples, and from a growing body of research, that also users may be the sources of innovation, which has major implications for academia, industry and policymaking. In this seminar, Prof. Eric von Hippel will build on his seminal work on the role of users in innovation to argue for a new “Free Innovation Paradigm” as a growing phenomenon. Prof Pedro Oliveira will furthermore explain the pivotal role that patients and caregivers play in the development, diffusion and adoption of certain innovations. On this basis, this seminar offers a platform to discuss the sources of health innovation, and the particular role of (the lack of) intellectual property (IP) in this context, as well as the implications for regulatory oversight (e.g. through the FDA & EMA) and for biomedical innovation in general. Because users as innovators fundamentally challenge the measurements, economics, business models and regulatory frameworks in the face of innovation, we need to discuss how researchers, practitioners and policymakers need to work with this growing phenomenon, and how bridging some of these domains and disciplines may help us in further developing this domain.


09:00 - 09:15 Welcome by Professor Timo Minssen, CeBIL – Innovating and regulating patient-driven innovation in the health sciences
09:15 - 09:45 Professor Eric von Hippel, MIT – “Free innovation - no IP required?”   In this lecture, Eric von Hippel starts by presenting survey findings showing that tens of millions of people spend tens of billions of dollars on product development for their personal purposes each year.  The investment level is similar in scale to spending by companies to develop new products for consumers - but is entirely invisible to economics because the developments are given away for free. He then offers a way to understand this growing phenomenon in terms of a new “Free Innovation Paradigm.” Free innovators are self-rewarded—by the benefits of their innovations, the intellectual stimulation involved in development, and the gratifications of altruism. Because they are self-rewarded, they can give away their innovations for free. Unlike producer innovators, free innovators can disregard the extent of the market, and so are often innovation pioneers. Free innovation poses a steadily stronger rival and complement to traditional producer innovation.  He will conclude by discussing the very positive implications of Free Innovation for producers and for society at large.
09:45 - 10:15 Professor Pedro Oliveira, CBS – “Development, diffusion and adoption of health innovations by patients and caregivers”   Consistent with the new “Free Innovation Paradigm” (e.g. von Hippel 2016), there is growing evidence that patients and their informal caregivers often develop innovative solutions to help them cope with their health disorders. In some cases, patients were even able to save their own lives. However, these innovations only rarely diffuse (e.g. Oliveira et al. 2015, Zejnilovic et al. 2016). To facilitate the sharing and diffusion of medical innovations developed by patients and caregivers, we created an online platform, where patients and caregivers can share solutions they developed for themselves to the benefit of others afflicted with the same health condition. In 4 years, over 1600 innovations were submitted (and about 850 were “medically screened” and approved by our medical team) from a community of 100.000 patients/caregivers in the 5 continents. In this talk we will discuss the potential of patients and their informal caregivers to both innovation and revolutionize healthcare.
10:15 - 10:45 Professor Marcel Bogers, IFRO: Panel Debate
10:45 - 11:00 Concluding remarks
11:00 - 11:30 Closing and refreshments


Please register no later than the 12th of October at 12:00.

About the speakers:

Professor Eric von Hippel
Eric von Hippel is T Wilson Professor of Innovation Management at the MIT Sloan School of Management, and Professor of Engineering Systems at MIT. Von Hippel is known for his research into the sources of innovation. He and his colleagues find that innovation is shifting away from product and service producers to product and service users in the Internet Age, and shifting from intellectual property protected to free. These important changes are driving major changes in innovation practice and theory. 

Professor Pedro Oliveira
Pedro Oliveira is Professor MSO at Copenhagen Business School with special responsibilities in healthcare innovation; He is also Academic Fellow at the Cornell Institute for Healthy Futures at Cornell University; Founder and President of Patient Innovation; and co-founder of PPL Crowdfunding. Pedro is Principal Investigator of several research grants.

Previously he was a Professor at Católica-Lisbon School of Business and Economics, where, among other, he served as Senior Associate Dean for Faculty and Research, Academic Director of the Lisbon MBA, and Director of the doctoral program in Technology Change and Entrepreneurship. He was also an International Faculty Fellow at MIT Sloan School of Management and Advisor to the Portuguese Ministry of Science, Technology and Higher Education.

He received his PhD in Operations, Technology and Innovation Management from the University of North Carolina at Chapel Hill; his M.Sc. in Operations Research and Systems Engineering; and his "licenciatura" in Naval Engineering from Instituto Superior Técnico in Portugal. He also completed some advanced training at Harvard Business School and Northwestern University’s Kellogg School of Management.

Professor Timo Minssen
Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founding Director of UCPH's Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research concentrates on Intellectual Property-, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors. This involves a plethora of legal issues emerging during the lifecycle of biotechnological and medical products and processes -  from the regulation of research and incentives for innovation to technology transfer and commercialization. Timo is presenting frequently on a wide variety of pressing topics at international IP symposia, major law firms, the Universities of Oxford & Cambridge, Harvard Law School, MIT, and at the European Medicines Agency etc.. He has written 2 books and published 80+ articles and book chapters in leading international publications, such as Nature Biotech, PLoS-Computational Biology, Biotech. J., BLR, Person.Med., IIC, EIPR, ECLR, JIPLP, GRUR Int., Chi.-Kent J. Intell. Prop., IPQ, QMJIP, ERT, NIR & EUConst.LR. He is also a regular contributor on Harvard Law School's "Bill of Health" blog. Prior to founding CeBIL, Timo headed CIIR's  Copenhagen Biotech & Pharma Forum (CBPF). 

Professor Marcel Bogers
Marcel Bogers is Professor of Innovation and Entrepreneurship at the University of Copenhagen. He works at the Unit for Innovation, Entrepreneurship and Management at the Department of Food and Resource Economics (Faculty of Science). He is also a senior research fellow (Garwood Research Fellow) at the Garwood Center for Corporate Innovation at the Haas School of Business, at the University of California, Berkeley. His main interests center on the design, organization and management of technology, innovation and entrepreneurship. More specifically, his research explores openness and participation in innovation and entrepreneurial processes within, outside and between organizations. In this context, he has studied issues such as open innovation, business models, family businesses, users as innovators, collaborative prototyping, improvisation, and university-industry collaboration.